Cubist Pharma (CBST) Q4, FY13 Revs Outpace Estimates; Issues Pipeline Update
Tweet Send to a Friend
Cubist Pharmaceuticals, Inc. (Nasdaq: CBST) announced unaudited fourth quarter and full-year 2013 revenues and a pipeline update as the Company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
